Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 96, Issue 6, 2000, Pages 707-711

  Flory, Janine D ^a,d   Manuck, Stephen B ^a   Ferrell, Robert E ^b   Ryan, Christopher M ^c   Muldoon, Matthew F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

APOE polymorphism; Cognitive performance; Middle age

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADULT; ALLELE; ALZHEIMER DISEASE; APTITUDE TEST; ARTICLE; ATTENTION; CAUCASIAN; COGNITIVE DEFECT; DISEASE MARKER; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY; ONSET AGE; PRIORITY JOURNAL; RECALL; RISK FACTOR; VISUAL MEMORY;

LONCHOCARPUS GLAUCIFOLIUS;

EID: 0034606329     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/1096-8628(20001204)96:6<707::aid-ajmg1>3.0.co;2-v     Document Type: Article

References (48)

1. APOE genotype influences functional status among elderly without dementia
2. Apolipoprotein E genotype and cognition in the very old
3. Early affect of APOE ε4 allele on cognitive results in a group of highly performing subjects: The EVA study
4. APOE-4 and age at onset of Alzheimer disease: The NIMH Genetics Initiative
5. Episodic memory changes are associated with the APOE ε4 allele in nondemented older adults
6. Tables for clinicians to use to convert WAIS-R short forms
7. Midlife cardiovascular risk factors, APOE, and cognitive decline in elderly twins
8. Preclinical memory decline in cognitively normal apolipoprotein E ε4 homozygotes
9. The underlying molecular mechanism of apolipoprotein E polymorphism: Relationships to lipid disorders, cardiovascular disease, and Alzheimer disease
10. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer disease in late-onset families
11. Apolipoprotein E polymorphism and atherosclerosis
12. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease
13. Apolipoprotein ε4 allele and cognitive decline in elderly men
14. The origins of individual differences in memory among the elderly: A behavior genetic analysis
15. Age differences in the nature and origin of individual differences in memory: A behavior genetic analysis
16. The association of apolipoprotein E polymorphism with memory: A population based study
17. Memory functions in human subjects with different apolipoprotein E pheno-types during a 3-year population-based follow-up study
18. Apolipoprotein E allele ε4, dementia, and cognitive decline in a population sample
19. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
20. Apolipoprotein E and cognitive change in an elderly population
21. Association between apolipoprotein E ε4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia
22. Relationship between APOE, MRI findings, and cognitive function in the cardiovascular health study
23. Exploring the etiology of Alzheimer disease using molecular genetics
24. Apolipoprotein E and Alzheimer disease: Ethnic variation in genotypic risks
25. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
26. Substantial genetic influence on cognitive abilities in twins 80 or more years old
27. APOE genotype predicts when - Not whether-one is predisposed to develop Alzheimer disease
28. A simple salting out procedure for extracting DNA from human nucleated cells
29. The APOE ε4 allele is associated with decline on delayed recall performance in community-dwelling older adults
30. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation
31. Gerontological behavior genetics
32. Apolipoprotein E status as a predictor of the development of Alzheimer disease in memory-impaired individuals
33. Apolipoprotein E ε4 allele and hippocampal volume in twins with normal cognition
34. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele
35. Preclinical evidence of Alzheimer disease in persons homozygous for the ε4 allele for apolipoprotein E
36. Apolipoprotein E alleles as risk factors in Alzheimer disease
37. Apolipoprotein E ε4 allele in the normal elderly: Neuropsychologic and brain MRI correlates
38. Three-year changes in cognitive performance as a function of apolipoprotein E genotype: Evidence from very old adults without dementia
39. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease
40. Memory self-appraisal in middleaged and older adults with the apolipoprotein E-4 allele
41. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer disease but not in healthy control subjects
42. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ε4 allele
43. The APOE ε4 allele and the risk of Alzheimer disease among African Americans, Whites, and Hispanics
44. Apolipoprotein E phenotypes, dementia, and mortality in a prospective population sample
45. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site
46. Human E apoprotein heterogeneity: Cysteine-arginine interchanges in the amino acid sequence of the APOE isoforms